TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in Urinary Melatonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Skin/Bed pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Concentrations of ANG II in Serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pooled sensitivity of endoscopic optical diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: incidence of dose limiting toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the levels of proinflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of the endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in indicators of diastolic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Single Leg Standing Test (SLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trost Selective Motor Control Test (TSMC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Roland Morris Disability Questionnaire (RMDQ) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in CRQ-SAI Dyspnea Domain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pectus Carinatum Evaluation Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of gene polymorphism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients who had SAC/VAL prescriptions filled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of patients who had abandoned (not accepted) SAC/VAL prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of patients who had SAC/VAL prescriptions rejected by an insurance payer
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean celecoxib CSF concentration (ug/L) within 121-180 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean celecoxib total and unbound plasma concentration (ug/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change in Hemoglobin A1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rates of interventions preferred by patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Operated limb edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of Early Acute Rejection (EAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Risk of Acute Cellular Rejection (ACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Risk of developing fibrosis of the allograft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in parental self-efficacy (PSE)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in parent oral health knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Follow up return rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 3-month recall return rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Knowledge Evaluation Scale for Pressure Ulcer Prevention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: CBCT navigation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: nCLE tool-in-lesion confirmation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Monocular intermediate visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory cell population
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Initial Ki67 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen Saturation Index (OSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of executive functions impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: incidence of Ventilator-Associated Pneumonia (VAP)
Endpoint domain: Adverse events/effects
Primary endpoint: Days of respiratory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Self-Reported Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sympathetic Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma (peak) drug concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach Cmax following drug administration (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of adherence to intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of sites successfully recruited
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Likert scale assessment of protocol implementation
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Likert scale assessment of participant satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in motor behavioral scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in somatosensory acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Shivering grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extracellular Matrix (ECM) deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Evaluation of scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Placebo-corrected change from baseline in PVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Adolescents Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Adolescent Sedentary Behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Adolescents Dietary Intake (i.e., Fruits/Vegetables)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Adolescents Dietary Intake (Sugar)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Erectile Function Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual Intercourse Satisfaction Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Hamilton Depression Scale-17 (HAMD-17)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reversal to sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Count of circulating tumor cells (CTCs) in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum Observed Serum Concentration (Cmax) of ABBV-319
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of days
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Percentage of participants accessing all four CC web application modules
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participants agreeing or strongly agreeing with helpfulness of CC web application
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of re-hospitalizations for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Time to first re-hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Scoliosis Research Society (SRS) 22r
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Oswestry
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient-Reported Outcome Measurement Information System (PROMIS) - Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-Reported Outcome Measurement Information System (PROMIS) - Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-Reported Outcome Measurement Information System (PROMIS) - Pain Interference
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: KSS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Post-operative leg alignment - Hip-knee-ankle axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose time in range (3.9-10 mmol/l)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: diffusing capacity for carbon monoxide (DLCO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: vascular parenchymal dysanapsis and cardiac chamber size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: airway-parenchymal dysanapsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Microvascular endothelial function (Cutaneous conductance, %maximum)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical event data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AUC 0-24 of NPRS-M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC 0-72 of NPRS-M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of heart failure decompensations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Physical activity lapse/intention-behavior gap
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: AUC over 24H of JLP-2008
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of JLP-2008
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TRG grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants with AEs and Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of midline shift (MLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in knee contact force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 6-month Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: 6-week Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Cell Count of Inflammatory Infiltrate Per Cross-Sectional Area at 400X Magnification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gap Distance of Inflammatory Resorption Between Inflamed Tissue and Root Surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Ligament Thickness of the Periodontal Ligament
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Validity of delirium screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: List and frequency of genetic anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant changes in clinical laboratory safety tests
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant changes in vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in food safety knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from Baseline in QT interval corrected by Fridericia (QTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of treatment-emergent clinically confirmed valvular heart disease (VHD)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in body weight (Z-score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of CSC/HTS-based combination drug therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of violence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hearing Aid Benefit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functionality as measured by ASES
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Tortuosity of the radial and subclavian arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Time needed for cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of crossover between approaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Perceived Threat of Alzheimer's Disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dementia Awareness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Generalized Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness of internal bleaching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Events related to Nexpowder
Endpoint domain: Adverse events/effects
Primary endpoint: Delayed bleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Start time assessment based on Parkinson's disease diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disabilities of Arm, Shoulder Hand questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Technology Acceptance Subscale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total CGM Use Time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Scan Time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Classification of CKD stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Acceptability of the email message program component
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of e-learning module program component
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EPIC patient portal usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Stress Response Inventory (SRI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hepatic enzyme abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HELLP Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Growth restricted fetus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of Participants With Healing Complication
Endpoint domain: Adverse events/effects
Primary endpoint: Circulating plasma tumour DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Circulating urine tumour DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: FFPE tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Grade 4 or new Grade 3 adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: area under the curve (AUC) of orally administered NTZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in concentrations of faecal and urinary metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in bacterial metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver cancer markers (AKR1B10, AFP, AFP-L3%, DCP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in dark-adapted full-field visual field sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in dark-adapted macular visual field sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in dark adaptometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ensuring Speech Understanding Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mini Mental State Exam scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Delayed Word Recall Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor recovery post-stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrical activity of spine extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Insulin secretion - c-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Volume of Alcohol Consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Breath Alcohol Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Fall Efficiency Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 12 months progression-free survival (PFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Periodontal Pocket Closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Revised Children's Anxiety and Depression Scale - Child Revised Short Version (RCADS-C-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Generalized Anxiety Disorder 7-item Scale (GAD-7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Health Questionnaire 9-item Scale (Modified for Major Depressive Disorder in Adolescents; PHQ-9M)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom From LBBAP Lead Related Serious Adverse Device Effects (SADEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Composite Success Rate of Acceptable Capture Thresholds and Sense Amplitudes for LBBAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Well-being at baseline
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Well-being at post-intervention timepoint
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Well-being at follow-up timepoint
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Assessment of radiographic healing with periapical (PA) radiographs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of radiographic healing with Cone beam computed tomography (CBCT) scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of clinical outcome by assessing the resolution/persistence/development of clinical signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HF parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reaching union
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: cognitive and intellectual function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: changes of the handgrip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of the gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of ED visits for opioid overdose/poisoning
Endpoint domain: Mortality/survival
Primary endpoint: Number of hospitalizations for opioid overdose/poisoning
Endpoint domain: Mortality/survival
Primary endpoint: Annualized rate of clinically significant exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boston Carpal Tunnel Syndrome Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TRACP-5b level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum C-reactive protein (CRP) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to successful radial arterial cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Neutralizing antibody GMT of Omicron BA.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Assessment of upper limb function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes